Cocrystal Non Currrent Assets Other from 2010 to 2025
| COCP Stock | USD 1.48 0.05 3.50% |
Non Currrent Assets Other | First Reported 2007-12-31 | Previous Quarter 29 K | Current Value 29 K | Quarterly Volatility 917.3 K |
Check Cocrystal Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cocrystal Pharma's main balance sheet or income statement drivers, such as Interest Expense of 1.7 K, Selling General Administrative of 4.1 M or Selling And Marketing Expenses of 8.9 M, as well as many indicators such as Price To Sales Ratio of 383, Dividend Yield of 0.0 or PTB Ratio of 0.69. Cocrystal financial statements analysis is a perfect complement when working with Cocrystal Pharma Valuation or Volatility modules.
Cocrystal | Non Currrent Assets Other |
Latest Cocrystal Pharma's Non Currrent Assets Other Growth Pattern
Below is the plot of the Non Currrent Assets Other of Cocrystal Pharma over the last few years. It is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. Cocrystal Pharma's Non Currrent Assets Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cocrystal Pharma's overall financial position and show how it may be relating to other accounts over time.
| Non Currrent Assets Other | 10 Years Trend |
|
Non Currrent Assets Other |
| Timeline |
Cocrystal Non Currrent Assets Other Regression Statistics
| Arithmetic Mean | (2,354,075) | |
| Coefficient Of Variation | (301.99) | |
| Mean Deviation | 4,451,606 | |
| Median | 46,000 | |
| Standard Deviation | 7,109,053 | |
| Sample Variance | 50.5T | |
| Range | 26.3M | |
| R-Value | 0.14 | |
| Mean Square Error | 53.1T | |
| R-Squared | 0.02 | |
| Significance | 0.61 | |
| Slope | 203,884 | |
| Total Sum of Squares | 758.1T |
Cocrystal Non Currrent Assets Other History
About Cocrystal Pharma Financial Statements
Cocrystal Pharma shareholders use historical fundamental indicators, such as Non Currrent Assets Other, to determine how well the company is positioned to perform in the future. Although Cocrystal Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in Cocrystal Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Cocrystal Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Non Currrent Assets Other | 52.9 K | 55.5 K |
Additional Tools for Cocrystal Stock Analysis
When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.